Engineered nanoparticles for the treatment of Alzheimer’s disease
Alzheimer’s disease (AD) is one of the most common diseases characterized by neurodegeneration and is becoming a major public health problem worldwide. AD is manifested mainly by progressive impairments in cognition, emotion, language and memory in the elderly population. Many treatment strategies h...
Saved in:
| Main Authors: | Jia Jia, Shuang Zhao, Jinghan Zhao, Yun Gao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1510798/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autophagy in alzheimer disease pathogenesis and its therapeutic values
by: Gabrielle Angst, et al.
Published: (2025-12-01) -
Enhanced Blood‐Brain Barrier Penetrability of BACE1 SiRNA‐Loaded Prussian Blue Nanocomplexes for Alzheimer's Disease Synergy Therapy
by: Xiaoyuan Ding, et al.
Published: (2025-08-01) -
Computational discovery of plant-derived flavonoids as potential amyloid-β fibril disaggregating agents for alzheimer’s disease
by: Uthirapathi Logeswari Rakesh, et al.
Published: (2025-06-01) -
Exploring efficient and effective mammalian models for Alzheimer’s disease
by: Mitsunori Kayano
Published: (2025-08-01) -
Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer’s disease in a mouse model
by: Ting-Ting Pan, et al.
Published: (2025-08-01)